CelluPro, ltd.

About CelluPro, ltd.

CelluPro provides high-performance cell culture media solutions for the global biopharmaceutical industry, supporting large-scale bioprocess development and commercial manufacturing with a focus on quality, consistency, and reliability.
As the first Chinese cell culture media supplier to support the commercial manufacturing of monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), CelluPro’s capabilities align with global regulatory standards, including FDA BLA and EMA approval requirements.
As part of the Rongchang Pharmaceuticals ecosystem, alongside RemeGen and MabPlex, CelluPro benefits from integrated expertise across the full biologics developme...

Certifications
  • Country/Region:
    China
  • Founded:
    2018
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from CelluPro, ltd. (1)

  • CelliMax® Integrated MSC Culture Solution

    Product CelliMax® Integrated MSC Culture Solution

    A comprehensive nutrient platform for multi-source mesenchymal stem cells (MSCs), designed for rapid expansion, high viability, and stable trilineage differentiation potential.
    ▪ Suitable for human MSCs derived from umbilical cord, adipose tissue, bone marrow, and amniotic membrane
    ▪ Serum-free a...